Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma
Yunxiu Luo,1,* Xiaopeng Huang,2,* Jiabin Zhan,3 Shuai Zhang2 1Department of Radiation Oncology, Hainan Cancer Hospital, Affiliated Cancer Hospital of Hainan Medical University, Haikou, 570311, Hainan Province, People’s Republic of China; 2Department of Radiation Oncology, Hainan Gene...
Enregistré dans:
Auteurs principaux: | Luo Y, Huang X, Zhan J, Zhang S |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a434fed3b60b491480c03dab9c98d34c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma
par: Shun Liu, et autres
Publié: (2021) -
A Novel Pyroptosis-related Prognostic Model for Hepatocellular Carcinoma
par: Qianqian Wu, et autres
Publié: (2021) -
SRD5A3-CDG: Emerging Phenotypic Features of an Ultrarare CDG Subtype
par: Nazreen Kamarus Jaman, et autres
Publié: (2021) -
Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5
par: Xuemei Yang, et autres
Publié: (2021) -
Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
par: Yumei Fan, et autres
Publié: (2021)